Arnon Rosenthal is the founder of Alector. Latest round: Series A. Backed by Polaris Venture Partners, OrbiMed Advisors. Based in South San Francisco, CA.
Arnon Rosenthal is the Co-Founder and CEO of Alector, a clinical-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's. He previously led Alector LLC, which secured Series A financing in 2013 to advance research into Alzheimer's treatments.
Full founder directory · Investor directory · Company funding database · Fundraising library